Clinical Trial Update: A Safety and Efficacy Study of DRM02 in Subjects With Rosacea [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of DRM02 in subjects with rosacea has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• DRM02

Snippet

Sponsor: Dermira, Inc. | Conditions: Rosacea | Phase 2 | Status: COMPLETED